17-42787442-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_032387.5(WNK4):​c.1641C>T​(p.Ala547Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0212 in 1,613,842 control chromosomes in the GnomAD database, including 2,899 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.074 ( 1231 hom., cov: 32)
Exomes 𝑓: 0.016 ( 1668 hom. )

Consequence

WNK4
NM_032387.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.202

Publications

9 publications found
Variant links:
Genes affected
WNK4 (HGNC:14544): (WNK lysine deficient protein kinase 4) This gene encodes a member of the WNK family of serine-threonine protein kinases. The kinase is part of the tight junction complex in kidney cells, and regulates the balance between NaCl reabsorption and K(+) secretion. The kinase regulates the activities of several types of ion channels, cotransporters, and exchangers involved in electrolyte flux in epithelial cells. Mutations in this gene result in pseudohypoaldosteronism type IIB.[provided by RefSeq, Sep 2009]
WNK4 Gene-Disease associations (from GenCC):
  • pseudohypoaldosteronism type 2B
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 17-42787442-C-T is Benign according to our data. Variant chr17-42787442-C-T is described in ClinVar as Benign. ClinVar VariationId is 323323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.202 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.23 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WNK4NM_032387.5 linkc.1641C>T p.Ala547Ala synonymous_variant Exon 7 of 19 ENST00000246914.10 NP_115763.2 Q96J92-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WNK4ENST00000246914.10 linkc.1641C>T p.Ala547Ala synonymous_variant Exon 7 of 19 1 NM_032387.5 ENSP00000246914.4 Q96J92-1

Frequencies

GnomAD3 genomes
AF:
0.0734
AC:
11148
AN:
151876
Hom.:
1217
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.233
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0298
Gnomad ASJ
AF:
0.00893
Gnomad EAS
AF:
0.0425
Gnomad SAS
AF:
0.105
Gnomad FIN
AF:
0.00462
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.00207
Gnomad OTH
AF:
0.0547
GnomAD2 exomes
AF:
0.0360
AC:
9040
AN:
251344
AF XY:
0.0351
show subpopulations
Gnomad AFR exome
AF:
0.238
Gnomad AMR exome
AF:
0.0160
Gnomad ASJ exome
AF:
0.0117
Gnomad EAS exome
AF:
0.0446
Gnomad FIN exome
AF:
0.00501
Gnomad NFE exome
AF:
0.00204
Gnomad OTH exome
AF:
0.0215
GnomAD4 exome
AF:
0.0157
AC:
23011
AN:
1461848
Hom.:
1668
Cov.:
33
AF XY:
0.0176
AC XY:
12774
AN XY:
727220
show subpopulations
African (AFR)
AF:
0.235
AC:
7877
AN:
33480
American (AMR)
AF:
0.0179
AC:
802
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0104
AC:
272
AN:
26136
East Asian (EAS)
AF:
0.0391
AC:
1553
AN:
39698
South Asian (SAS)
AF:
0.100
AC:
8641
AN:
86258
European-Finnish (FIN)
AF:
0.00525
AC:
280
AN:
53384
Middle Eastern (MID)
AF:
0.0189
AC:
109
AN:
5768
European-Non Finnish (NFE)
AF:
0.00150
AC:
1665
AN:
1112006
Other (OTH)
AF:
0.0300
AC:
1812
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.538
Heterozygous variant carriers
0
1486
2973
4459
5946
7432
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
388
776
1164
1552
1940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0737
AC:
11206
AN:
151994
Hom.:
1231
Cov.:
32
AF XY:
0.0734
AC XY:
5452
AN XY:
74304
show subpopulations
African (AFR)
AF:
0.234
AC:
9684
AN:
41384
American (AMR)
AF:
0.0298
AC:
455
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00893
AC:
31
AN:
3472
East Asian (EAS)
AF:
0.0428
AC:
221
AN:
5162
South Asian (SAS)
AF:
0.105
AC:
505
AN:
4796
European-Finnish (FIN)
AF:
0.00462
AC:
49
AN:
10600
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.00207
AC:
141
AN:
67980
Other (OTH)
AF:
0.0541
AC:
114
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.540
Heterozygous variant carriers
0
421
842
1262
1683
2104
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
120
240
360
480
600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0291
Hom.:
1283
Bravo
AF:
0.0799
Asia WGS
AF:
0.0820
AC:
285
AN:
3478
EpiCase
AF:
0.00245
EpiControl
AF:
0.00219

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 15, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Pseudohypoaldosteronism type 2B Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
1.5
DANN
Benign
0.38
PhyloP100
0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9916754; hg19: chr17-40939460; COSMIC: COSV55902593; COSMIC: COSV55902593; API